Published 2 months ago

Molnupiravir: COVID drug linked to mutations that could 'spread the illness', scientists say

A study has found that the antiviral drug molnupiravir can cause mutations in the COVID-19 virus, potentially leading to further infection and genetic diversity in the surviving viral population.
These mutations were more likely in older age groups, which aligns with the use of antiviral treatment in higher-risk individuals.
The findings of the study have raised questions about the overall benefits and risks of molnupiravir and similar drugs, urging regulators to consider the possibility of persistent antiviral-induced mutations when developing new treatments.

Insights by Ground AI

Does this summary seem wrong?

More
Filters

29 Articles

All

Left

Center

Right

The Guardian

Use of antiviral may be fuelling evolution of Covid, scientists say

Study finds evidence virus can survive treatment with molnupiravir, leading to mutated versions that sometimes spreadAn antiviral drug used to treat patients with Covid-19 may be causing mutations in the virus and fuelling the evolution of new variants, scientists have said.Molnupiravir, which is also sold under the brand name Lagevrio, is designed to mutate coronavirus to destruction, but researchers found evidence that the virus can sometimes …

2 months ago·London, United Kingdom

Read Full Article

The Independent

Antiviral Covid drug linked to virus mutations, study suggests

Researchers say their findings are helpful in the ongoing assessment of the risks and benefits of molnupiravir treatment.

2 months ago·London, United Kingdom

Read Full Article

Daily Express

Warning as popular Covid antiviral drug is driving unexpected mutations

Molnupiravir was one of the first antivirals available on the market during the COVID-19 pandemic, and was employed by many countries, including the US, particularly against chronic infections.

2 months ago·United Kingdom

Read Full Article

CNBC

Merck Covid drug linked to virus mutations that can spread between people, new study says

There is still no evidence that molnupiravir, sold under the brand name Lagevrio, has produced more transmissible or severe variants of Covid.

2 months ago·United States

Read Full Article

South China Morning Post

Anti-Covid drug may have led to virus mutations: study

Pharmaceutical giant Merck’s antiviral pill molnupiravir was one of the earliest treatments rolled out during the pandemic to prevent Covid becoming more severe in vulnerable people.

2 months ago·Hong Kong

Read Full Article

Channel News Asia

Anti-COVID drug may have led to virus mutations: Study

PARIS: An anti-COVID drug widely used across the world may have caused mutations in the virus, researchers said on Monday (Sep 25), but there was no evidence that the changes had led to more dangerous variants. Pharmaceutical giant Merck's antiviral pill molnupiravir was one of the earliest treatments

2 months ago·Singapore

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year